a magnifying glass

adobe pdf icon Analogic Launches LIFEGARD I Non-Invasive Patient Monitor

Analogic Launches LIFEGARD I Non-Invasive Patient Monitor

Analogic Launches LIFEGARD I Non-Invasive Patient Monitor

PEABODY, Mass.–(BUSINESS WIRE)–Jan. 16, 2007–Analogic
Corporation (NASDAQ: ALOG) today announced the official product launch
of the LIFEGARD® I non-invasive patient monitor for continuous
monitoring as well as for single spot-check measurements of vital
signs. One of the most versatile patient monitors in its class, the
LIFEGARD I is successor to the Company’s popular LIFEGARD patient

The LIFEGARD I, the latest in a series of non-invasive patient
monitors from Analogic, measures ECG, HR, SpO2, NIBP, and Predictive
Temperature (optional), and has network communication capability with
the LIFEGARD Vue Central Nurses’ Station.

Designed primarily for continuous patient monitoring in
low-acuity-care areas with full patient alarm capability, the LIFEGARD
I can also be easily employed as a stat- or spot-check monitor for use
either in the physician’s office or from patient to patient within the
ward. When using “spot-check” mode, all audible alarms are
automatically disabled, a new patient identification is assigned for
each new set of measurements, and previous patient data can be deleted

Its integral battery, with 4 to 8 hours of operating time,
combined with its light weight (less than 5 lbs.), compact “go
anywhere” housing, and ergonomic handle, make the LIFEGARD I an ideal
choice for transport and for first-responders. Its easy-to-use,
intuitive user interface is consistent with the other LIFEGARD

Dan Webster, General Manager of Analogic’s Life Care Systems
Division, noted, “The LIFEGARD I is a significant addition to our
growing LIFEGARD family of non-invasive patient monitors. The portable
LIFEGARD I brings a new level of versatility to patient monitoring by
allowing clinicians to utilize it almost anywhere in the hospital,
including general care, ED, triage and recovery areas, or in non-acute
environments such as freestanding clinics and physicians’ offices.”

Analogic’s LIFEGARD family of non-invasive patient monitors also
includes LIFEGARD II, a uniquely powerful monitor that measures ECG,
HR, SpO2, NIBP, Continual NIBP, Temperature, Respiration, end tidal
CO2, Non-Invasive Cardiac Output via impedance cardiography, and 17
derived hemodynamic parameters; LIFEGARD ICG, a standalone
Non-Invasive Cardiac Output and hemodynamic status monitor; and the
LIFEGARD Vue Central Nurses’ Station. Additional models with expanded
capabilities that have already received U.S. Food & Drug
Administration (FDA) clearance will be launched over the next 12
months. For more information on LIFEGARD I or any other monitors in
the LIFEGARD family, go to www.analogic.com/lifegard, or call

Analogic offers a complete line of accessories for all LIFEGARD
family products as well as reusable and disposable supplies.
Accessories and supplies may be purchased through your local dealer or
at Analogic’s LIFEGARD e-store: www.analogic.com/lifegardstore.

Analogic Corporation is a leading designer and manufacturer of
advanced health and security systems and subsystems sold primarily to
Original Equipment Manufacturers (OEMs). The Company is recognized
worldwide for advancing the state of the art in Computed Tomography
(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging
(MRI), and Patient Monitoring.

Analogic Corporation
Paul M. Roberts, 978-326-4213
Director of Communications


Analogic Corporation